Archives
-
WZ4003: From Target Engagement to Tau Biology
2026-09-12
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase engagement with cell migration, proliferation, invasion, and tau biology. This evidence-calibrated guide explains how to design assays that distinguish direct NUAK signaling from dose, tissue, and culture-context effects.
-
RIPA Lysis Buffer (Strong) for Protein Workflows
2026-09-11
RIPA Lysis Buffer (Strong) supports reproducible protein extraction from cultured cells, animal tissues, and isolated exosome preparations for Western blotting, ELISA, and selected immunoprecipitation workflows. This guide translates a macrophage–enteric neuron study into practical lysate preparation, assay-selection, and troubleshooting decisions.
-
Protease Inhibitor Cocktail: EDTA-Free Workflow Guide
2026-09-11
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during cell lysis, protein extraction, and culture-based sample preparation. It is appropriate for workflows sensitive to added EDTA, but it should not be treated as a complete metalloprotease inhibitor or used without checking DMSO and assay compatibility.
-
Nitrocefin Workflows for β-Lactamase Assays
2026-09-10
Build faster, more interpretable β-lactamase experiments with Nitrocefin, from bacterial lysate profiling to inhibitor validation. This guide combines practical assay parameters, controls, troubleshooting, and a structure-guided peptide-screening case study.
-
Rice Stripe Virus NS3 Rewires Host Kinase Signaling
2026-09-10
Zhuang et al. show that Rice stripe virus NS3 uses stage-dependent phosphorylation and protein interactions to redirect the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway. The study explains how RSV balances antiviral RNA interference, reactive oxygen species signaling, programmed cell death, host damage, and transmission across plant, vector, and viral contexts.
-
DMG-PEG2000-NH2: LNP Workflow Guide
2026-09-09
Build more deliberate liposome and lipid nanoparticle workflows with a primary amine PEG linker designed for carboxyl coupling, surface functionalization, and siRNA delivery research. This guide combines practical conjugation parameters with assay lessons from sulfaphenazole optimization, while clearly separating established findings from formulation starting points.
-
Sulfo-NHS-SS-Biotin for Reliable Cell Assays
2026-09-09
This scenario-driven guide explains how Sulfo-NHS-SS-Biotin, SKU A8005, can add a reversible cell-surface protein readout to viability, proliferation, and cytotoxicity workflows. It covers compatibility, fresh-solution handling, interpretation, and practical vendor-selection criteria supported by product specifications and relevant receptor-trafficking literature.
-
ICG001: A Wnt/β-catenin Pathway Inhibitor
2026-09-08
ICG001 selectively disrupts the CBP/β-catenin transcriptional axis, making it useful for separating pathway activation from downstream gene-expression output. This guide applies the compound to cancer, fibrosis, stem-cell, and osteogenesis workflows while emphasizing dose design, controls, and interpretation limits.
-
Phosphorylated NPY1R Drives Intracranial Aneurysm Progressio
2026-09-08
This December 2024 study identifies phosphorylated NPY1R as a mechanistic link between vascular smooth muscle cell phenotypic transition, inflammatory signaling, macrophage infiltration, and intracranial aneurysm progression. Its combination of patient tissues, hypertensive elastase-induced mice, molecular assays, kinase inhibition, and macrophage ablation provides a framework for testing NPY1R-centered disease mechanisms while highlighting important limits in translating the findings to other vascular models.
-
Caspase-3 Fluorometric Assay Kit Workflow
2026-09-07
Convert DEVD-AFC cleavage into a rapid, quantitative apoptosis readout for treatment comparisons, pathway mapping, and ferroptosis–apoptosis studies. This workflow combines practical assay design with troubleshooting guidance for reliable caspase activity measurement in complex cell-death models.
-
D-Luciferin Workflows for Tumor Bioluminescence
2026-09-07
D-Luciferin turns firefly luciferase reporters into a practical readout for longitudinal tumor burden assessment, gene-expression studies, and intracellular ATP quantification. This workflow-focused guide shows how to apply the substrate to tumor-targeted immunotherapy models while controlling for delivery, enzyme activity, and biological confounders.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-09-05
Build a reproducible fluorescence workflow for rabbit primary antibodies across immunofluorescence, IHC, ICC, and flow cytometry. This guide connects Cy3 signal amplification with an ovarian cancer polarity study, showing how to turn localization data into experimentally testable EMT and Wnt/β-catenin hypotheses.
-
PAD4, NETs, and Actionable Cell-Death Data
2026-09-04
PAD4-targeted strategies can suppress tumor growth and metastasis through neutrophil NET biology without directly killing tumor cells. This thought-leadership guide shows how Annexin V-APC/7-AAD phenotyping can clarify that distinction and strengthen translational study design.
-
Reactive Oxygen Species Assay Kit Workflow
2026-09-04
Use the Reactive Oxygen Species Assay Kit to connect live-cell ROS changes with radiosensitization, nanoparticle treatment, viability, and DNA-damage workflows. Its DCFH-DA fluorescent probe and Rosup positive control provide a practical framework for comparing oxidative responses to FLASH-RT, conventional radiotherapy, or candidate therapies.
-
Angiotensin II, LOX-1, and Redox-Sensitive Angiogenesis
2026-09-03
This reference study identified a mechanistic feedback loop in which Angiotensin II activates AT1R, increases LOX-1 and oxidative signaling, and promotes VEGF-dependent capillary formation. By combining human endothelial-cell assays with mouse aortic-ring experiments and genetic LOX-1 deficiency, the work connected receptor signaling to an angiogenic phenotype and established a useful framework for vascular mechanism studies.